Genetic variants in FAS and CASP10 genes identified in the patient cohort
Affected gene . | HGVS RNA . | HGVS amino acid change . | Mechanism . | ACMG . | Patients, % (n = 86) . | MAF in general population . | Provean . | SIFT . | MetaSVM . | Grantham score . | HSF (splice) . | Previously published in ALPS . | Diagnosis . | Non evaluable . | Study conclusion . | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Definite . | Suspected . | Unlikely . | |||||||||||||||
FAS | c.76C>T | p.Gln26Ter | Nonsense | Pathogenic | 1.16 | 0 | — | — | — | — | — | No | 1 | 0 | 0 | 0 | Pathogenic |
FAS | c.219C>A | p.Cys73Ter | Nonsense | pathogenic | 1.16 | 0 | — | — | — | — | — | Yes ALPS1,2 | 1 | 0 | 0 | 0 | Pathogenic |
FAS | c.715_721delGTCATGA | p.Val239HisfsTer2 | Frameshift | Pathogenic | 1.16 | 0 | — | — | — | — | — | No | 1 | 0 | 0 | 0 | Pathogenic |
FAS | c.719_722delinsAGTTA | p.Met240LysfsTer7 | Frameshift | Pathogenic | 1.16 | 0 | — | — | — | — | — | No | 1 | 0 | 0 | 0 | Pathogenic |
FAS | c.742T>G | p.Phe248Val | Missense | Likely pathogenic | 3.49 | 0 | Damaging | Damaging | Damaging | 50 | — | No | 3 | 0 | 0 | 0 | Pathogenic |
FAS | c.749G>A | p.Arg250Gln | Missense | Likely pathogenic | 5.81 | 0 | Damaging | Damaging | Damaging | 43 | Yes ALPS2,3 | 3 | 1 | 0 | 1 | Pathogenic | |
FAS | c.776T>G | p.Ile259Arg | Missense | Likely pathogenic | 1.163 | 0 | Damaging | Damaging | Damaging | 97 | Yes ALPS4 | 0 | 0 | 0 | 1 | Pathogenic | |
FAS | c.794A>G | p.Asp265Gly | Missense | Likely pathogenic | 1.16% | 0 | Damaging | Damaging | Damaging | 94 | No | 1 | 0 | 0 | 0 | Pathogenic | |
FAS | c.826C>A | p.Gln276Lys | Missense | Likely pathogenic | 2.33 | 0 | Neutral | Tolerated/ damaging | Damaging | 53 | No | 1 | 1 | 0 | 0 | Pathogenic | |
FAS | c.335-9_335-6delATTT | Intronic | Splice possible | VUS | 1.16 | 0 | — | — | — | — | Alteration of WT acceptor site | No | 1 | 0 | 0 | 0 | Pathogenic |
FAS | c.136A>C | p.Thr46Pro | Missense | VUS | 1.16 | 0.00003 | Neutral | Tolerated | Tolerated | 38 | Potential | No | 0 | 0 | 1 | 0 | VUS, Benign |
FAS | c.642T>C | p.Thr214 = | Synonymous SNP | Benign | 3.49 | 0.766 | — | — | — | — | No impact | NA | 2 | 1 | 0 | 0 | Benign |
FAS | c.196+176C>T | Intronic | Intronic SNP | Benign | 1.16 | 0.394 | — | — | — | — | No impact | NA | 0 | 1 | 0 | 0 | Benign |
FAS | c.334+46C>T | Intronic | Intronic SNP | Benign | 1.16 | 0.165 | — | — | — | — | No impact | NA | 1t | 0 | 0 | 0 | Benign |
FAS | c.505+82C>G | Intronic | Intronic SNP | Benign | 1.16 | 0.387 | — | — | — | — | No impact | NA | 0 | 1 | 0 | 0 | Benign |
FAS | c.506-71C>G | Intronic | Intronic SNP | Benign | 1.16 | 0.387 | — | — | — | — | No impact | NA | 0 | 1 | 0 | 0 | Benign |
FAS | c.677-95T>C | Intronic | Intronic SNP | Benign | 1.16 | 0.0392 | — | — | — | — | — | NA | 1 | 0 | 0 | 0 | Benign |
CASP10 | c.1216A>T | p.Ile406Leu | Missense | Likely benign | 4.65 | 0.00456 | Neutral | Tolerated | Tolerated | 5 | Potential | Yes ALPS | 1 | 1 | 0 | 2 | VUS |
CASP10 | c.1228G>A | p.Val410Ile | Missense | Benign | 1.16 | 0.0445 | Neutral | Tolerated | Tolerated | 29 | NA | Yes controversial | 0 | 1 | 0 | 0 | Likely benign |
CASP10 | c.295A>G | p.Lys99Glu | Missense | Likely benign | 1.16 | 0.00039 | Neutral/damaging | Tolerated/damaging | Tolerated | 56 | Potential | NO | 1 | 0 | 0 | 0 | VUS |
Affected gene . | HGVS RNA . | HGVS amino acid change . | Mechanism . | ACMG . | Patients, % (n = 86) . | MAF in general population . | Provean . | SIFT . | MetaSVM . | Grantham score . | HSF (splice) . | Previously published in ALPS . | Diagnosis . | Non evaluable . | Study conclusion . | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Definite . | Suspected . | Unlikely . | |||||||||||||||
FAS | c.76C>T | p.Gln26Ter | Nonsense | Pathogenic | 1.16 | 0 | — | — | — | — | — | No | 1 | 0 | 0 | 0 | Pathogenic |
FAS | c.219C>A | p.Cys73Ter | Nonsense | pathogenic | 1.16 | 0 | — | — | — | — | — | Yes ALPS1,2 | 1 | 0 | 0 | 0 | Pathogenic |
FAS | c.715_721delGTCATGA | p.Val239HisfsTer2 | Frameshift | Pathogenic | 1.16 | 0 | — | — | — | — | — | No | 1 | 0 | 0 | 0 | Pathogenic |
FAS | c.719_722delinsAGTTA | p.Met240LysfsTer7 | Frameshift | Pathogenic | 1.16 | 0 | — | — | — | — | — | No | 1 | 0 | 0 | 0 | Pathogenic |
FAS | c.742T>G | p.Phe248Val | Missense | Likely pathogenic | 3.49 | 0 | Damaging | Damaging | Damaging | 50 | — | No | 3 | 0 | 0 | 0 | Pathogenic |
FAS | c.749G>A | p.Arg250Gln | Missense | Likely pathogenic | 5.81 | 0 | Damaging | Damaging | Damaging | 43 | Yes ALPS2,3 | 3 | 1 | 0 | 1 | Pathogenic | |
FAS | c.776T>G | p.Ile259Arg | Missense | Likely pathogenic | 1.163 | 0 | Damaging | Damaging | Damaging | 97 | Yes ALPS4 | 0 | 0 | 0 | 1 | Pathogenic | |
FAS | c.794A>G | p.Asp265Gly | Missense | Likely pathogenic | 1.16% | 0 | Damaging | Damaging | Damaging | 94 | No | 1 | 0 | 0 | 0 | Pathogenic | |
FAS | c.826C>A | p.Gln276Lys | Missense | Likely pathogenic | 2.33 | 0 | Neutral | Tolerated/ damaging | Damaging | 53 | No | 1 | 1 | 0 | 0 | Pathogenic | |
FAS | c.335-9_335-6delATTT | Intronic | Splice possible | VUS | 1.16 | 0 | — | — | — | — | Alteration of WT acceptor site | No | 1 | 0 | 0 | 0 | Pathogenic |
FAS | c.136A>C | p.Thr46Pro | Missense | VUS | 1.16 | 0.00003 | Neutral | Tolerated | Tolerated | 38 | Potential | No | 0 | 0 | 1 | 0 | VUS, Benign |
FAS | c.642T>C | p.Thr214 = | Synonymous SNP | Benign | 3.49 | 0.766 | — | — | — | — | No impact | NA | 2 | 1 | 0 | 0 | Benign |
FAS | c.196+176C>T | Intronic | Intronic SNP | Benign | 1.16 | 0.394 | — | — | — | — | No impact | NA | 0 | 1 | 0 | 0 | Benign |
FAS | c.334+46C>T | Intronic | Intronic SNP | Benign | 1.16 | 0.165 | — | — | — | — | No impact | NA | 1t | 0 | 0 | 0 | Benign |
FAS | c.505+82C>G | Intronic | Intronic SNP | Benign | 1.16 | 0.387 | — | — | — | — | No impact | NA | 0 | 1 | 0 | 0 | Benign |
FAS | c.506-71C>G | Intronic | Intronic SNP | Benign | 1.16 | 0.387 | — | — | — | — | No impact | NA | 0 | 1 | 0 | 0 | Benign |
FAS | c.677-95T>C | Intronic | Intronic SNP | Benign | 1.16 | 0.0392 | — | — | — | — | — | NA | 1 | 0 | 0 | 0 | Benign |
CASP10 | c.1216A>T | p.Ile406Leu | Missense | Likely benign | 4.65 | 0.00456 | Neutral | Tolerated | Tolerated | 5 | Potential | Yes ALPS | 1 | 1 | 0 | 2 | VUS |
CASP10 | c.1228G>A | p.Val410Ile | Missense | Benign | 1.16 | 0.0445 | Neutral | Tolerated | Tolerated | 29 | NA | Yes controversial | 0 | 1 | 0 | 0 | Likely benign |
CASP10 | c.295A>G | p.Lys99Glu | Missense | Likely benign | 1.16 | 0.00039 | Neutral/damaging | Tolerated/damaging | Tolerated | 56 | Potential | NO | 1 | 0 | 0 | 0 | VUS |
Genetic variants (coding sequence and protein changes) are listed according to the recommendations of the Human Genome Variation Society (HGVS) nomenclature. Classification by ACMG is shown according to populational frequencies, previous literature data, and in silico predictions, such as Provean, SIFT, MetaSVM.
HSF, Human Splicing Finder (Web-based splice site prediction); MAF, minor allele frequency; NA, not applicable; SNP, single-nucleotide polymorphism.